Systematic benchmarking of nanopore Q20+ kit in SARS-CoV-2 whole genome sequencing
Junhong Luo(Nanjing Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Lingfeng Mao, Xiaojuan Zhu(University of Tennessee at Knoxville), Xingyu Xu, Lei Wang(UCSF Helen Diller Family Comprehensive Cancer Center), Qiao Qiao(Jiangsu Provincial Center for Disease Control and Prevention), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Zixinrong Meng(Nanjing Medical University)
Cited by 43
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204